Bridges Investment Management Inc. Makes New $206,000 Investment in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Bridges Investment Management Inc. acquired a new position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 3,216 shares of the company’s stock, valued at approximately $206,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Hollencrest Capital Management purchased a new position in Ryan Specialty during the 3rd quarter worth approximately $25,000. Assetmark Inc. purchased a new position in Ryan Specialty during the 3rd quarter worth approximately $34,000. Principal Securities Inc. boosted its stake in shares of Ryan Specialty by 164.7% during the 4th quarter. Principal Securities Inc. now owns 667 shares of the company’s stock valued at $43,000 after buying an additional 415 shares during the period. Quarry LP boosted its stake in shares of Ryan Specialty by 109.3% during the 3rd quarter. Quarry LP now owns 808 shares of the company’s stock valued at $54,000 after buying an additional 422 shares during the period. Finally, Loomis Sayles & Co. L P boosted its stake in shares of Ryan Specialty by 26.3% during the 3rd quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock valued at $91,000 after buying an additional 286 shares during the period. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Nicholas Dominic Cortezi sold 35,000 shares of the business’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $67.39, for a total transaction of $2,358,650.00. Following the transaction, the director now owns 65,100 shares in the company, valued at approximately $4,387,089. The trade was a 34.97 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders sold a total of 316,451 shares of company stock valued at $20,907,793 in the last quarter. Insiders own 11.10% of the company’s stock.

Ryan Specialty Stock Down 0.9 %

RYAN stock opened at $69.38 on Tuesday. The firm has a market cap of $18.17 billion, a PE ratio of 100.55, a PEG ratio of 1.19 and a beta of 0.72. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a 1 year low of $48.48 and a 1 year high of $75.97. The company has a fifty day simple moving average of $66.13 and a 200 day simple moving average of $67.47.

Ryan Specialty (NYSE:RYAN) last released its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). The firm had revenue of $663.53 million for the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. Sell-side analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th will be given a dividend of $0.12 per share. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend is Tuesday, March 4th. This represents a $0.48 dividend on an annualized basis and a yield of 0.69%. Ryan Specialty’s payout ratio is currently 69.57%.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the stock. Royal Bank of Canada decreased their target price on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research note on Friday, February 21st. Wells Fargo & Company lifted their target price on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a research note on Friday, February 21st. Barclays lifted their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. Morgan Stanley assumed coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They set an “overweight” rating and a $90.00 target price for the company. Finally, Keefe, Bruyette & Woods decreased their target price on shares of Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating for the company in a research note on Friday, February 21st. One investment analyst has rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Ryan Specialty has a consensus rating of “Hold” and a consensus target price of $75.27.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.